Copertina

Pharmacokinetic study of iptacopan and its two acyl glucuronide metabolites in monkey plasma by liquid chromatography combined with electrospray ionization tandem mass spectrometry

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Jingchu Li, Shanshan Liu, Chenglin Jia, Jiacheng Li, Zhihui Zhang, Jian Chen, Yongbin Cao, Chao Ma
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Biomedical Chromatography
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Identification of the metabolites of nimbolide in rat by liquid chromatography combined with quadrupole/orbitrap mass spectrometry
di: Kun Li, et al.
Pubblicazione: (2024)

Quantitation of tazemetostat in human plasma using liquid chromatography–tandem mass spectrometry
di: Marco Orleni, et al.
Pubblicazione: (2024)

Pharmacokinetics of IMM‐H012 in rats using ultra‐performance liquid chromatography‐tandem mass spectrometry
di: Shujuan Wu, et al.
Pubblicazione: (2024)

A simple and sensitive liquid chromatography triple quadrupole mass spectrometry method for the determination of XL092 in monkey plasma and its application to pharmacokinetic study
di: Cui Li, et al.
Pubblicazione: (2024)

A simple and sensitive ultra‐high performance liquid chromatography tandem mass spectrometry method for the quantitative analysis of VX‐548 in monkey plasma: Method validation and application to pharmacokinetic study
di: Huiying Zhang, et al.
Pubblicazione: (2024)

Simultaneous determination of four fungicide residues in figs using liquid chromatography tandem mass spectrometry
di: Feng Lan, et al.
Pubblicazione: (2024)

In vivo detection of the epimer metabolites of sweroside via ultra‐performance liquid chromatography time‐of‐flight mass spectrometry combined with DNPH derivatization
di: Hao Li, et al.
Pubblicazione: (2024)

Liquid chromatography–tandem mass spectrometry for determination of fingolimod and its active metabolite fingolimod phosphate in whole blood of patients with multiple sclerosis
di: Veronika Pesakova, et al.
Pubblicazione: (2024)

Assessment of remdesivir and its nucleoside metabolite in beagle dogs and healthy humans by liquid chromatography coupled with triple quadrupole mass spectrometry
di: Naveen Kumar Dubey, et al.
Pubblicazione: (2024)

Liquid chromatography–tandem mass spectrometry determination of bumetanide in human plasma and application to a clinical pharmacokinetic study
di: Ganesan Padmini Tamilarasi, et al.
Pubblicazione: (2024)

Identifying chemical markers in wine‐processed Salvia miltiorrhiza using ultrahigh‐performance liquid chromatography‐quadrupole‐time‐of‐flight‐tandem mass spectrometry
di: Tingting Xu, et al.
Pubblicazione: (2024)

Analysis of blood concentrations and clinical application of risdiplam in patients with spinal muscular atrophy using ultra‐high performance liquid chromatography–tandem mass spectrometry
di: Xian Wu, et al.
Pubblicazione: (2024)

Metabolite profiling of liquiritin in acute myocardial infarction model rat after intragastric administration using an information‐dependent acquisition‐mediated ultra‐high‐performance liquid chromatography‐tandem mass spectrometry method
di: Jian Chen, et al.
Pubblicazione: (2024)

Ultra‐high‐performance liquid chromatography–mass spectrometry combined with molecular docking and molecular dynamics simulation reveals the source of bitterness in the traditional Chinese medicine formula Runchang‐Tongbian
di: Na Li, et al.
Pubblicazione: (2024)

Highly sensitive liquid chromatography–mass spectrometry method for the quantitative analysis of mometasone furoate in human plasma: Method validation and application to clinical pharmacokinetic studies
di: Olivier Heudi, et al.
Pubblicazione: (2024)

Analysis of omarigliptin forced degradation products by ultra‐fast liquid chromatography, mass spectrometry, and in vitro toxicity assay
di: Amanda Mohr, et al.
Pubblicazione: (2024)

Insight gained via ultra‐performance liquid chromatography tandem mass spectrometry‐based metabolomics: Protective effect of Artemisia argyi H.Lév. & Vaniot essential oil on lipopolysaccharide‐induced liver injury mice
di: Hui Zhou, et al.
Pubblicazione: (2024)

Uncovering the material basis and mechanism of Jianwei Xiaoshi tablet against functional dyspepsia using ultra‐high‐performance liquid chromatography‐mass spectrometry and network pharmacology
di: Xiaoxu Cheng, et al.
Pubblicazione: (2024)

Identification of Xuanfei Baidu granule constituents by liquid chromatography–quadruple‐time‐of‐flight–mass spectrometry and its anti‐inflammatory active constituents using a lipopolysaccharide‐induced RAW264.7 cell model
di: Haoran Li, et al.
Pubblicazione: (2024)

A strategy to comprehensively and quickly identify the chemical constituents in Wuteng tablets by ultra‐high‐performance liquid chromatography coupled to quadrupole time‐of‐flight mass spectrometry
di: Pengyi Chen, et al.
Pubblicazione: (2024)

Analytical determination of ethylenediamine impurity in tripelennamine hydrochloride by gas chromatography–mass spectrometry using phthalaldehyde as the derivatizing agent
di: Sayyad Kousrali, et al.
Pubblicazione: (2024)

Quantitative Analysis of the Active Metabolite of VX‐150 Using UPLC–MS/MS: A Preclinical Pharmacokinetic Study in Rats
di: Xia Feng, et al.
Pubblicazione: (2025)

An effective LC–MS method for the simultaneous determination of a potential anti‐rheumatoid arthritis drug, carboxyamidotriazole, and its major metabolite in rat plasma
di: Xuli Lang, et al.
Pubblicazione: (2024)

LC–HRMS methods for the quantification of two artemisinin drugs and their metabolites in rat blood and plasma
di: Hongchang Zhou, et al.
Pubblicazione: (2024)

Evaluation of various polysaccharide‐based stationary phases for enantioseparation of chloro‐containing derivatives in normal phase liquid chromatography
di: Alina Ghinet, et al.
Pubblicazione: (2024)

Development of a green high‐performance liquid chromatography method for tofacitinib quantification in pharmaceutical formulations and degradation studies
di: Gizem Tiris, et al.
Pubblicazione: (2024)

Bone and periosteum protein analysis via tandem mass tag quantitative proteomics in pediatric patients with osteomyelitis
di: Xinwu Wu, et al.
Pubblicazione: (2024)

Advances in mass spectrometry for metabolomics: Strategies, challenges, and innovations in disease biomarker discovery
di: Nikhil Titkare, et al.
Pubblicazione: (2024)

Validation and optimisation of reduced glutathione quantification in erythrocytes by means of a coulometric high‐performance liquid chromatography analytical method
di: Stef Lauwers, et al.
Pubblicazione: (2024)

Spectrum–effect relationship between ultra‐performance liquid chromatography fingerprints and melanogenic effect of Vernonia anthelmintica effective part
di: Xiaoling Ma, et al.
Pubblicazione: (2024)

Quantitation of the DNA‐dependent protein kinase inhibitor peposertib (M3814) and metabolite in human plasma by LC–MS/MS
di: Susan M. Christner, et al.
Pubblicazione: (2024)

Spectrum–effect relationship study between ultra‐high‐performance liquid chromatography fingerprints and anti‐hepatoma effect in vitro of Cnidii Fructus
di: Zhenguo Lv, et al.
Pubblicazione: (2024)

Pharmacokinetic Study of Ginkgolide B in Dog After Intravenous Administration
di: Li Li, et al.
Pubblicazione: (2025)

Supercritical fluid chromatography for milligram preparation of enantiomers
di: Naomi Knavs, et al.
Pubblicazione: (2024)

Simultaneous quantification of icaritin and its novel 3‐methylcarbamate prodrug in rat plasma using HPLC–MS/MS and its application to pharmacokinetic study
di: Fengxiao Li, et al.
Pubblicazione: (2024)

Pharmacokinetic study of multicomponent in Hong‐Hua‐Xiao‐Yao tablet
di: Xiaofeng Li, et al.
Pubblicazione: (2024)

Establishing a multi‐method approach for unprecedented detection and quantification of 13 genotoxic impurities (GTIs) in Apixaban drug substance through ultra‐performance liquid chromatography (UPLC)
di: Sivaprasadu Ganta, et al.
Pubblicazione: (2024)

Gas chromatography mass spectrometer determination of dimethylamine impurity in N,N‐dimethylformamide solvent by derivatization of N,N‐dimethylbenzamide with benzoyl chloride agent
di: Sayyad Kousrali, et al.
Pubblicazione: (2024)

Pharmacokinetic and oral bioavailability study of schaftoside in rats
di: Yuan Lin, et al.
Pubblicazione: (2024)

Characterization of Pharmacokinetics and Oral Bioavailability of Saikosaponin A in Rats Using a Validated UFLC–MS/MS Method
di: Zhongwen Sun, et al.
Pubblicazione: (2025)